Cargando…
Machine learning cardiac-MRI features predict mortality in newly diagnosed pulmonary arterial hypertension
AIMS: Pulmonary arterial hypertension (PAH) is a rare but serious disease associated with high mortality if left untreated. This study aims to assess the prognostic cardiac magnetic resonance (CMR) features in PAH using machine learning. METHODS AND RESULTS: Seven hundred and twenty-three consecutiv...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9708011/ https://www.ncbi.nlm.nih.gov/pubmed/36713008 http://dx.doi.org/10.1093/ehjdh/ztac022 |
_version_ | 1784840827526184960 |
---|---|
author | Alabed, Samer Uthoff, Johanna Zhou, Shuo Garg, Pankaj Dwivedi, Krit Alandejani, Faisal Gosling, Rebecca Schobs, Lawrence Brook, Martin Shahin, Yousef Capener, Dave Johns, Christopher S Wild, Jim M Rothman, Alexander M K van der Geest, Rob J Condliffe, Robin Kiely, David G Lu, Haiping Swift, Andrew J |
author_facet | Alabed, Samer Uthoff, Johanna Zhou, Shuo Garg, Pankaj Dwivedi, Krit Alandejani, Faisal Gosling, Rebecca Schobs, Lawrence Brook, Martin Shahin, Yousef Capener, Dave Johns, Christopher S Wild, Jim M Rothman, Alexander M K van der Geest, Rob J Condliffe, Robin Kiely, David G Lu, Haiping Swift, Andrew J |
author_sort | Alabed, Samer |
collection | PubMed |
description | AIMS: Pulmonary arterial hypertension (PAH) is a rare but serious disease associated with high mortality if left untreated. This study aims to assess the prognostic cardiac magnetic resonance (CMR) features in PAH using machine learning. METHODS AND RESULTS: Seven hundred and twenty-three consecutive treatment-naive PAH patients were identified from the ASPIRE registry; 516 were included in the training, and 207 in the validation cohort. A multilinear principal component analysis (MPCA)-based machine learning approach was used to extract mortality and survival features throughout the cardiac cycle. The features were overlaid on the original imaging using thresholding and clustering of high- and low-risk of mortality prediction values. The 1-year mortality rate in the validation cohort was 10%. Univariable Cox regression analysis of the combined short-axis and four-chamber MPCA-based predictions was statistically significant (hazard ratios: 2.1, 95% CI: 1.3, 3.4, c-index = 0.70, P = 0.002). The MPCA features improved the 1-year mortality prediction of REVEAL from c-index = 0.71 to 0.76 (P ≤ 0.001). Abnormalities in the end-systolic interventricular septum and end-diastolic left ventricle indicated the highest risk of mortality. CONCLUSION: The MPCA-based machine learning is an explainable time-resolved approach that allows visualization of prognostic cardiac features throughout the cardiac cycle at the population level, making this approach transparent and clinically interpretable. In addition, the added prognostic value over the REVEAL risk score and CMR volumetric measurements allows for a more accurate prediction of 1-year mortality risk in PAH. |
format | Online Article Text |
id | pubmed-9708011 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-97080112023-01-27 Machine learning cardiac-MRI features predict mortality in newly diagnosed pulmonary arterial hypertension Alabed, Samer Uthoff, Johanna Zhou, Shuo Garg, Pankaj Dwivedi, Krit Alandejani, Faisal Gosling, Rebecca Schobs, Lawrence Brook, Martin Shahin, Yousef Capener, Dave Johns, Christopher S Wild, Jim M Rothman, Alexander M K van der Geest, Rob J Condliffe, Robin Kiely, David G Lu, Haiping Swift, Andrew J Eur Heart J Digit Health Original Article AIMS: Pulmonary arterial hypertension (PAH) is a rare but serious disease associated with high mortality if left untreated. This study aims to assess the prognostic cardiac magnetic resonance (CMR) features in PAH using machine learning. METHODS AND RESULTS: Seven hundred and twenty-three consecutive treatment-naive PAH patients were identified from the ASPIRE registry; 516 were included in the training, and 207 in the validation cohort. A multilinear principal component analysis (MPCA)-based machine learning approach was used to extract mortality and survival features throughout the cardiac cycle. The features were overlaid on the original imaging using thresholding and clustering of high- and low-risk of mortality prediction values. The 1-year mortality rate in the validation cohort was 10%. Univariable Cox regression analysis of the combined short-axis and four-chamber MPCA-based predictions was statistically significant (hazard ratios: 2.1, 95% CI: 1.3, 3.4, c-index = 0.70, P = 0.002). The MPCA features improved the 1-year mortality prediction of REVEAL from c-index = 0.71 to 0.76 (P ≤ 0.001). Abnormalities in the end-systolic interventricular septum and end-diastolic left ventricle indicated the highest risk of mortality. CONCLUSION: The MPCA-based machine learning is an explainable time-resolved approach that allows visualization of prognostic cardiac features throughout the cardiac cycle at the population level, making this approach transparent and clinically interpretable. In addition, the added prognostic value over the REVEAL risk score and CMR volumetric measurements allows for a more accurate prediction of 1-year mortality risk in PAH. Oxford University Press 2022-05-02 /pmc/articles/PMC9708011/ /pubmed/36713008 http://dx.doi.org/10.1093/ehjdh/ztac022 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the European Society of Cardiology. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Alabed, Samer Uthoff, Johanna Zhou, Shuo Garg, Pankaj Dwivedi, Krit Alandejani, Faisal Gosling, Rebecca Schobs, Lawrence Brook, Martin Shahin, Yousef Capener, Dave Johns, Christopher S Wild, Jim M Rothman, Alexander M K van der Geest, Rob J Condliffe, Robin Kiely, David G Lu, Haiping Swift, Andrew J Machine learning cardiac-MRI features predict mortality in newly diagnosed pulmonary arterial hypertension |
title | Machine learning cardiac-MRI features predict mortality in newly diagnosed pulmonary arterial hypertension |
title_full | Machine learning cardiac-MRI features predict mortality in newly diagnosed pulmonary arterial hypertension |
title_fullStr | Machine learning cardiac-MRI features predict mortality in newly diagnosed pulmonary arterial hypertension |
title_full_unstemmed | Machine learning cardiac-MRI features predict mortality in newly diagnosed pulmonary arterial hypertension |
title_short | Machine learning cardiac-MRI features predict mortality in newly diagnosed pulmonary arterial hypertension |
title_sort | machine learning cardiac-mri features predict mortality in newly diagnosed pulmonary arterial hypertension |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9708011/ https://www.ncbi.nlm.nih.gov/pubmed/36713008 http://dx.doi.org/10.1093/ehjdh/ztac022 |
work_keys_str_mv | AT alabedsamer machinelearningcardiacmrifeaturespredictmortalityinnewlydiagnosedpulmonaryarterialhypertension AT uthoffjohanna machinelearningcardiacmrifeaturespredictmortalityinnewlydiagnosedpulmonaryarterialhypertension AT zhoushuo machinelearningcardiacmrifeaturespredictmortalityinnewlydiagnosedpulmonaryarterialhypertension AT gargpankaj machinelearningcardiacmrifeaturespredictmortalityinnewlydiagnosedpulmonaryarterialhypertension AT dwivedikrit machinelearningcardiacmrifeaturespredictmortalityinnewlydiagnosedpulmonaryarterialhypertension AT alandejanifaisal machinelearningcardiacmrifeaturespredictmortalityinnewlydiagnosedpulmonaryarterialhypertension AT goslingrebecca machinelearningcardiacmrifeaturespredictmortalityinnewlydiagnosedpulmonaryarterialhypertension AT schobslawrence machinelearningcardiacmrifeaturespredictmortalityinnewlydiagnosedpulmonaryarterialhypertension AT brookmartin machinelearningcardiacmrifeaturespredictmortalityinnewlydiagnosedpulmonaryarterialhypertension AT shahinyousef machinelearningcardiacmrifeaturespredictmortalityinnewlydiagnosedpulmonaryarterialhypertension AT capenerdave machinelearningcardiacmrifeaturespredictmortalityinnewlydiagnosedpulmonaryarterialhypertension AT johnschristophers machinelearningcardiacmrifeaturespredictmortalityinnewlydiagnosedpulmonaryarterialhypertension AT wildjimm machinelearningcardiacmrifeaturespredictmortalityinnewlydiagnosedpulmonaryarterialhypertension AT rothmanalexandermk machinelearningcardiacmrifeaturespredictmortalityinnewlydiagnosedpulmonaryarterialhypertension AT vandergeestrobj machinelearningcardiacmrifeaturespredictmortalityinnewlydiagnosedpulmonaryarterialhypertension AT condlifferobin machinelearningcardiacmrifeaturespredictmortalityinnewlydiagnosedpulmonaryarterialhypertension AT kielydavidg machinelearningcardiacmrifeaturespredictmortalityinnewlydiagnosedpulmonaryarterialhypertension AT luhaiping machinelearningcardiacmrifeaturespredictmortalityinnewlydiagnosedpulmonaryarterialhypertension AT swiftandrewj machinelearningcardiacmrifeaturespredictmortalityinnewlydiagnosedpulmonaryarterialhypertension |